Abiopharma

🔍 Romano Kelly A (Executive)

Company: LeonaBio, Inc. (LONA)

Report Date: 2026-06-23

Detailed Transactions and Holdings:

• Acquired 28,000 shares of Stock Option (Right to Buy) at $8.35 per share (Derivative)
  Date: 2026-06-23 | Code: A | Expires: 2036-06-22 | equity_swap_involved: 0 | shares_owned_after: 28,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy.